• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预处理中洗脱期的意义。

The significance of the washout period in preconditioning.

作者信息

Salie Ruduwaan, Lochner Amanda, Loubser Dirk J

机构信息

Biomedical Research and Innovation Platform, South African Medical Research Council, Parow Valley, Cape Town, South Africa.

Faculty of Medicine and Health Sciences, Division of Medical Physiology, University of Stellenbosch, Tygerberg, Cape Town, South Africa.

出版信息

Cardiovasc Ther. 2017 Jun;35(3). doi: 10.1111/1755-5922.12252.

DOI:10.1111/1755-5922.12252
PMID:28118517
Abstract

AIMS

Exposure of the heart to 5 min global ischaemia (I) followed by 5 min reperfusion (R) (ischaemic preconditioning, IPC) or transient Beta 2-adrenergic receptor (B2-AR) stimulation with formoterol (B2PC), followed by 5 min washout before index ischaemia, elicits cardioprotection against subsequent sustained ischaemia. As the washout period during preconditioning is essential for subsequent cardioprotection, the aim of this study was to investigate the involvement of protein kinase A (PKA), reactive oxygen species (ROS), extracellular signal-regulated kinase (ERK), PKB/Akt, p38 MAPK and c-jun N-terminal kinase (JNK) during this period.

METHODS

Isolated perfused rat hearts were exposed to IPC (1x5min I / 5min R) or B2PC (1x5min Formoterol / 5min R) followed by 35 min regional ischaemia and reperfusion. Inhibitors for PKA (Rp-8CPT-cAMP)(16μM), ROS (NAC)(300μM), PKB (A-6730)(2.5μM), ERKp44/p42 (PD98,059)(10μM), p38MAPK (SB239063)(1μM) or JNK (SP600125)(10μM) were administered for 5 minutes before 5 minutes global ischaemia / 5 min reperfusion (IPC) or for 5 minutes before and during administration of formoterol (B2PC) prior to regional ischaemia, reperfusion and infarct size (IS) determination. Hearts exposed to B2PC or IPC were freeze-clamped during the washout period for Western blots analysis of PKB, ERKp44/p42, p38MAPK and JNK.

RESULTS

The PKA blocker abolished both B2PC and IPC, while NAC significantly increased IS of IPC but not of B2PC. Western blot analysis showed that ERKp44/p42 and PKB activation during washout after B2PC compared to IPC was significantly increased. IPC compared to B2PC showed significant p38MAPK and JNKp54/p46 activation. PKB and ERK inhibition or p38MAPK and JNK inhibition during the washout period of B2PC and IPC respectively, significantly increased IS.

CONCLUSION

PKA activation before regional ischaemia is a prerequisite for cardioprotection in both B2PC and IPC. However, ROS was crucial only in IPC. Kinase activation during the washout phase of IPC and B2PC, albeit different, affords the same cardioprotective response.

摘要

目的

使心脏经历5分钟全心缺血(I),随后5分钟再灌注(R)(缺血预处理,IPC),或用福莫特罗进行短暂β2 -肾上腺素能受体(B2 - AR)刺激(B2PC),然后在指数缺血前进行5分钟洗脱,可诱导对随后持续缺血的心脏保护作用。由于预处理期间的洗脱期对随后的心脏保护至关重要,本研究的目的是探讨在此期间蛋白激酶A(PKA)、活性氧(ROS)、细胞外信号调节激酶(ERK)、蛋白激酶B/蛋白激酶B(PKB/Akt)、p38丝裂原活化蛋白激酶(MAPK)和c - jun N端激酶(JNK)的作用。

方法

将离体灌注大鼠心脏暴露于IPC(1×5分钟I / 5分钟R)或B2PC(1×5分钟福莫特罗 / 5分钟R),随后进行35分钟局部缺血和再灌注。在5分钟全心缺血/5分钟再灌注(IPC)前5分钟或在局部缺血、再灌注和梗死面积(IS)测定前给予PKA抑制剂(Rp - 8CPT - cAMP)(16μM)、ROS抑制剂(NAC)(300μM)、PKB抑制剂(A - 6730)(2.5μM)、ERKp44/p42抑制剂(PD98,059)(10μM)、p38MAPK抑制剂(SB239063)(1μM)或JNK抑制剂(SP600125)(10μM)5分钟,或在给予福莫特罗(B2PC)前及给药期间5分钟给予上述抑制剂。在洗脱期对暴露于B2PC或IPC的心脏进行冷冻钳夹,用于对PKB、ERKp44/p42、p38MAPK和JNK进行蛋白质印迹分析。

结果

PKA阻滞剂消除了B2PC和IPC的保护作用,而NAC显著增加了IPC组的梗死面积,但对B2PC组无此作用。蛋白质印迹分析显示,与IPC相比,B2PC后洗脱期ERKp44/p42和PKB的活化显著增加。与B2PC相比,IPC显示出显著的p38MAPK和JNKp54/p46活化。分别在B2PC和IPC的洗脱期抑制PKB和ERK或抑制p38MAPK和JNK,显著增加了梗死面积。

结论

局部缺血前PKA活化是B2PC和IPC心脏保护的前提条件。然而,ROS仅在IPC中起关键作用。IPC和B2PC洗脱期的激酶活化虽不同,但产生相同的心脏保护反应。

相似文献

1
The significance of the washout period in preconditioning.预处理中洗脱期的意义。
Cardiovasc Ther. 2017 Jun;35(3). doi: 10.1111/1755-5922.12252.
2
Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.缺血预处理和β-肾上腺素能预处理对心肌细胞凋亡的抑制作用依赖于p38丝裂原活化蛋白激酶。
Cardiovasc Drugs Ther. 2006 Feb;20(1):13-25. doi: 10.1007/s10557-006-6257-7.
3
Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.缺血预处理中的激酶和磷酸酶:再评价。
Basic Res Cardiol. 2010 Jul;105(4):495-511. doi: 10.1007/s00395-010-0086-3. Epub 2010 Feb 2.
4
The mechanism of beta-adrenergic preconditioning: roles for adenosine and ROS during triggering and mediation.β肾上腺素能预处理的机制:触发和介导过程中腺苷和 ROS 的作用。
Basic Res Cardiol. 2012 Sep;107(5):281. doi: 10.1007/s00395-012-0281-5. Epub 2012 Jul 15.
5
Early ischaemic preconditioning requires Akt- and PKA-mediated activation of eNOS via serine1176 phosphorylation.早期缺血预处理需要通过 Akt 和 PKA 介导的 eNOS 丝氨酸 1176 磷酸化来激活。
Cardiovasc Res. 2013 Jan 1;97(1):33-43. doi: 10.1093/cvr/cvs287. Epub 2012 Sep 12.
6
CREB activation and ischaemic preconditioning.CREB激活与缺血预处理
Cardiovasc Drugs Ther. 2008 Feb;22(1):3-17. doi: 10.1007/s10557-007-6078-3. Epub 2008 Jan 20.
7
Cardioprotective Effects of Beta3-Adrenergic Receptor (β3-AR) Pre-, Per-, and Post-treatment in Ischemia-Reperfusion.β3-肾上腺素能受体(β3-AR)预处理、共处理和后处理对缺血再灌注的心脏保护作用。
Cardiovasc Drugs Ther. 2019 Apr;33(2):163-177. doi: 10.1007/s10557-019-06861-5.
8
p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning.p38丝裂原活化蛋白激酶(MAPK)的激活引发了药理学诱导的β-肾上腺素能预处理,但未引发缺血预处理。
J Mol Cell Cardiol. 2001 Dec;33(12):2157-77. doi: 10.1006/jmcc.2001.1478.
9
Protection of the ischaemic heart: investigations into the phenomenon of ischaemic preconditioning.缺血性心脏的保护:对缺血预处理现象的研究。
Cardiovasc J Afr. 2009 Jan-Feb;20(1):43-51.
10
GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways.GSK-3β 在心脏预适应信号通路的十字路口:mTOR 和 Wnt 通路的影响。
Cardiovasc Res. 2011 Apr 1;90(1):49-56. doi: 10.1093/cvr/cvr002. Epub 2011 Jan 13.

引用本文的文献

1
Preconditioning or Postconditioning with 8-Br-cAMP-AM Protects the Heart against Regional Ischemia and Reperfusion: A Role for Mitochondrial Permeability Transition.8-Br-cAMP-AM 的预处理或后处理可保护心脏免受局部缺血再灌注损伤:线粒体通透性转换的作用。
Cells. 2021 May 17;10(5):1223. doi: 10.3390/cells10051223.